Innate immune regulation of inflammation and adaptive immunity
Innate immune regulation of inflammation and adaptive immunity
批准号:
8105430
负责人:
Anthony L Defranco
金额:
$173.36万
依托单位国家:
美国
项目类别:
财政年份:
2008
资助国家:
美国
项目状态:
已结题
起止时间:
2008-07-15 至 2013-06-30
中文摘要
点击翻译按钮获取中文摘要
英文摘要
DESCRIPTION (provided by applicant): In recent years, Innate Immunity has gone from being the "immunologists' dirty little secret" to being among the most active and exciting areas of immunology. Many recognition molecules of vertebrate innate immune cells have been defined and much is now known about their mechanisms of action. Nonetheless, much remains to be learned before we truly understand how to harness these mechanisms for vaccination and cancer immunotherapy or how to block them to treat autoimmune and inflammatory disease. This proposed Program Project combines 4 investigators with established expertise in the area of innate immunity to pursue related studies developing out of their independent research efforts, but containing numerous connections and great potential for combined effort. In Project #1, Dr. DeFranco will utilize his newly created conditional allele of myd88 to dissect the cellular basis of Toll-like receptor signaling for systemic and mucosal immune responses, with emphasis on airways and fungal infections. In Project #2, Dr. Ma will analyze the role of the ubiquitin-modifying regulator A20 in dendritic cells for restraining TLR responses and preventing inflammatory disease. In Project #3, Dr. Lowell will determine the mechanism by which myeloid cells contribute to lupus-like autoimmunity in the Lyn-deficient mouse model. Finally, in Project #4, Dr. Locksley will determine how chitin, a polysaccharide found in fungi and invertebrates, promotes type 2 immunity and how it interacts with TLR signaling pathways to regulate the type of immune response. Lay Language: The immune system recognizes conserved elements of viruses, bacteria, fungi and multicellular invertebrates to allow it to detect infections and fight them. Immunologists are defining a number of the molecular mechanisms by which this is done, but much remains to be learned, particularly to understand how these reactions are controlled to avoid excessive inflammation and tissue injury, while directing the immune system toward the type of immune response most beneficial for fighting the infectious agent that is present. Better understanding of these issues will lead to improved vaccination procedures and better ability to control excessive inflammatory conditions.
期刊论文(0)
专著(0)
科研奖励(0)
会议论文
Organ-specific autoimmunity resulting from two genetic defects in tolerance
-
批准号:10341142
-
项目类别:
-
资助金额:$40.38万
-
财政年份:2018
-
负责人:Anthony L Defranco
-
依托单位:
B cell TLRs and germinal centers
-
批准号:8869351
-
项目类别:
-
资助金额:$23.78万
-
财政年份:2015
-
负责人:Anthony L Defranco
-
依托单位:
B cell TLRs and germinal centers
-
批准号:9097649
-
项目类别:
-
资助金额:$19.81万
-
财政年份:2015
-
负责人:Anthony L Defranco
-
依托单位:
BCR regulation of antibody responses
-
批准号:8876974
-
项目类别:
-
资助金额:$30.55万
-
财政年份:2014
-
负责人:Anthony L Defranco
-
依托单位:
The role of Apobec3 enzymes in regulation of marginal zone B cells
-
批准号:8564959
-
项目类别:
-
资助金额:$22.14万
-
财政年份:2013
-
负责人:Anthony L Defranco
-
依托单位:
The role of Apobec3 enzymes in regulation of marginal zone B cells
-
批准号:8664346
-
项目类别:
-
资助金额:$19.75万
-
财政年份:2013
-
负责人:Anthony L Defranco
-
依托单位:
Cell Type-Specific Roles of TLR Signaling In Immune Responses
-
批准号:7370266
-
项目类别:
-
资助金额:$38.56万
-
财政年份:2008
-
负责人:Anthony L Defranco
-
依托单位:
Innate immune regulation of inflammation and adaptive immunity
-
批准号:8306848
-
项目类别:
-
资助金额:$171.23万
-
财政年份:2008
-
负责人:Anthony L Defranco
-
依托单位:
Cell Type-Specific Roles of TLR Signaling In Immune Responses
-
批准号:8004106
-
项目类别:
-
资助金额:$37.86万
-
财政年份:2008
-
负责人:Anthony L Defranco
-
依托单位:
Innate immune regulation of inflammation and adaptive immunity
-
批准号:7651357
-
项目类别:
-
资助金额:$181.77万
-
财政年份:2008
-
负责人:Anthony L Defranco
-
依托单位:
Cell Type-Specific Roles of TLR Signaling In Immune Responses
-
批准号:7751933
-
项目类别:
-
资助金额:$38.24万
-
财政年份:2008
-
负责人:Anthony L Defranco
-
依托单位:
Innate immune regulation of inflammation and adaptive immunity
-
批准号:7888367
-
项目类别:
-
资助金额:$180.71万
-
财政年份:2008
-
负责人:Anthony L Defranco
-
依托单位:
Cell Type-Specific Roles of TLR Signaling In Immune Responses
-
批准号:8206583
-
项目类别:
-
资助金额:$37.86万
-
财政年份:2008
-
负责人:Anthony L Defranco
-
依托单位:
Cell Type-Specific Roles of TLR Signaling In Immune Responses
-
批准号:7535224
-
项目类别:
-
资助金额:$38.63万
-
财政年份:2008
-
负责人:Anthony L Defranco
-
依托单位:
IMMUNOGLOBULIN HEAVY CHAIN IN B LYMPHOCYTE DEVELOPMENT
-
批准号:6302353
-
项目类别:
-
资助金额:$16.12万
-
财政年份:2000
-
负责人:Anthony L Defranco
-
依托单位:
IMMUNOGLOBULIN HEAVY CHAIN IN B LYMPHOCYTE DEVELOPMENT
-
批准号:6110481
-
项目类别:
-
资助金额:$16.12万
-
财政年份:1999
-
负责人:Anthony L Defranco
-
依托单位:
SELECTIVE GENE ABLATION IN MATURE B LYMPHOCYTES
-
批准号:2558214
-
项目类别:
-
资助金额:$2.0万
-
财政年份:1998
-
负责人:Anthony L Defranco
-
依托单位:
IMMUNOGLOBULIN HEAVY CHAIN IN B LYMPHOCYTE DEVELOPMENT
-
批准号:6273065
-
项目类别:
-
资助金额:$15.57万
-
财政年份:1998
-
负责人:Anthony L Defranco
-
依托单位:
IMMUNOGLOBULIN HEAVY CHAIN IN B LYMPHOCYTE DEVELOPMENT
-
批准号:6242475
-
项目类别:
-
资助金额:$14.92万
-
财政年份:1997
-
负责人:Anthony L Defranco
-
依托单位:
Cytoskeleton and Signal Transduction in Host Defense
-
批准号:7174861
-
项目类别:
-
资助金额:$35.91万
-
财政年份:1994
-
负责人:Anthony L Defranco
-
依托单位:
国内基金
海外基金
登录
查看更多内容
声致离子电流促进小胶质细胞M2极化阻断再生神经瘢痕退变免疫机制
-
批准号:82371973
-
项目类别:面上项目
-
资助金额:48.00万元
-
批准年份:2023
-
负责人:孙迪
-
依托单位:
转运蛋白RCP调控巨噬细胞脂肪酸氧化参与系统性红斑狼疮发病的机制研究
-
批准号:82371798
-
项目类别:面上项目
-
资助金额:49.00万元
-
批准年份:2023
-
负责人:叶俊娜
-
依托单位:
基于FCER1G基因介导免疫反应探讨迟发性聋与认知障碍相关性的机制研究
-
批准号:82371141
-
项目类别:面上项目
-
资助金额:49.00万元
-
批准年份:2023
-
负责人:陈颖
-
依托单位:
CD27-CD28-CD8+T细胞调控儿童肝脏移植免疫耐受形成的作用和机制
-
批准号:82371791
-
项目类别:面上项目
-
资助金额:49.00万元
-
批准年份:2023
-
负责人:刘永波
-
依托单位:
T细胞受体NRP1作为新型免疫检查点在去势抵抗性前列腺癌中的作用机制研究
-
批准号:32100631
-
项目类别:青年科学基金项目(C类)
-
资助金额:30.0万元
-
批准年份:2021
-
负责人:刘飞
-
依托单位:
抑制FGF19/FGFR4信号通路促进肺鳞癌细胞焦亡及免疫增效的机制研究
-
批准号:32100565
-
项目类别:青年科学基金项目(C类)
-
资助金额:30.0万元
-
批准年份:2021
-
负责人:李凡
-
依托单位:
间充质干细胞通过CD73/CD39/腺苷-PI3K/Akt-Nrf2信号轴调节CD4+IL-10+IFN-γ+T细胞分化减弱GVHD机制研究
-
批准号:32070781
-
项目类别:面上项目
-
资助金额:58.0万元
-
批准年份:2020
-
负责人:栾希英
-
依托单位:
自噬基因Epg5在诺如病毒感染过程中的作用
-
批准号:32070745
-
项目类别:面上项目
-
资助金额:58.0万元
-
批准年份:2020
-
负责人:路群
-
依托单位:
C9ORF72-SMCR8复合物在小胶质细胞中的功能及其介导的炎症反应
-
批准号:32070743
-
项目类别:面上项目
-
资助金额:58.0万元
-
批准年份:2020
-
负责人:杨玫
-
依托单位:
MET通过MTOR介导的自噬调节肝癌免疫原性和治疗抗性的作用及机制研究
-
批准号:31970696
-
项目类别:面上项目
-
资助金额:58.0万元
-
批准年份:2019
-
负责人:黄星
-
依托单位: